Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2012
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173099A1 Endothelial-lipase-inhibiting amino derivative
12/20/2012WO2012172887A1 Therapeutic agent for heart diseases and cell sheet for treating heart diseases
12/20/2012WO2012171135A1 Benzofuran compound, preparation method and use thereof
12/20/2012WO2012118308A3 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
12/20/2012US20120322884 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
12/20/2012US20120322880 Pharmaceutical Formulations of Modafinil
12/20/2012US20120322875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2012US20120322868 Food products, preparation, and therapeutic methods
12/20/2012US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
12/20/2012US20120322861 Compositions and Methods for Treating Diseases
12/20/2012US20120322860 Aptamer therapeutics useful in the treatment of complement-related disorders
12/20/2012US20120322856 Method for Promoting Angiogenesis, Vascularization, or Vessel Repair or for the Inhibiting Tumor Angiogenesis
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322838 Epothilone Compounds, Preparation Method and Use Thereof
12/20/2012US20120322836 Pharmaceutical compositions and methods for stabilizing the same
12/20/2012US20120322835 Pharmaceutical compositions and methods for producing low impurity concentrations of the same
12/20/2012US20120322830 Cyclourea Compounds as Calcium Channel Blockers
12/20/2012US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
12/20/2012US20120322819 Compound containing a novel 4-alkoxypyrimidine structure and medicine containing same
12/20/2012US20120322816 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012US20120322810 New salts
12/20/2012US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/20/2012US20120322806 Quinoxalinedione derivatives
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322796 Benzocycloheptane and benzoxepine derivatives
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322772 Substituted imidazopyrimidines and triazolopyrimidines
12/20/2012US20120322761 Heterocyclic cetp inhibitors
12/20/2012US20120322760 Methods of treatment with a low molecular weight heparin composition
12/20/2012US20120322751 use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals
12/20/2012US20120322724 Molecules for targeting compounds to various selected organs or tissues
12/20/2012US20120321724 Method of Measuring and Monitoring In Vivo Nitrite Levels
12/20/2012US20120321720 Therapeutic application of parenteral krill oil
12/20/2012US20120321712 Pharmaceutical Composition
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321708 Sustained-release formulations of topiramate
12/20/2012US20120321704 Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof
12/20/2012US20120321692 Methods and Dressings for Sealing Internal Injuries
12/20/2012US20120321650 Composition for the treatment of atherosclerosis
12/20/2012US20120321640 Von willebrand factor specific binding agents and uses thereof
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321627 Bispecific anti-vegf/anti-ang-2 antibodies
12/20/2012US20120321602 Omega-3 fatty acid nutriceutical composition and optimization method
12/20/2012US20120321595 Treatment of heart disease
12/20/2012US20120321591 Anti-angiogenic compounds
12/20/2012US20120321584 Processes for preparing amine salts of kmup-3 and use thereof
12/20/2012US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same
12/20/2012US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
12/20/2012CA2839438A1 Agents and methods for treating ischemic and other diseases
12/20/2012CA2836804A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/19/2012EP2535410A1 Aptamer to fgf2 and use thereof
12/19/2012EP2535329A2 Spiro-piperidine derivatives
12/19/2012EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012EP2534135A2 Novel forms of ivabradine hydrochloride
12/19/2012EP2533637A1 Chromone inhibitors of s-nitrosoglutathione reductase
12/19/2012CN202605350U Application for treating phlebitis
12/19/2012CN1823071B Thienopyrimidine derivatives as potassium channel inhibitors
12/19/2012CN102834400A 2,5-substituted oxazolopyrimidine derivatives
12/19/2012CN102834399A Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
12/19/2012CN102834396A Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
12/19/2012CN102834383A Cysteine protease inhibitors
12/19/2012CN102834380A Inhibitors of protein kinases
12/19/2012CN102834101A Biodegradable material containing silicon, for pro-angiogenetic therapy
12/19/2012CN102827875A Recombinant adenovirus for expressing mouse nerve growth factors and preparation method thereof
12/19/2012CN102827739A Health-care salvia miltiorrhiza wine for invigorate blood circulation
12/19/2012CN102827735A Health-care wine for enriching blood, relaxing bowel, reducing phlegm and depressing blood-fat
12/19/2012CN102827233A Ester derivatives of ginsenoside Compound K and application thereof in preparing drugs of preventing and treating atherosclerosis
12/19/2012CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof
12/19/2012CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof
12/19/2012CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine
12/19/2012CN102827184A Polymorph of 2-hydroxy tetrahydrothienopyridine derivatives and pharmaceutical composition
12/19/2012CN102827153A Crystal form of azilsartan and preparation method thereof
12/19/2012CN102827081A Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
12/19/2012CN102827001A Ilex kudingcha C.J.Tseng extract
12/19/2012CN102824644A High-stability sustained-release tablet prepared by using hydroxy propyl cellulose
12/19/2012CN102824619A Pharmaceutical composition for treating ischemic cerebrovascular diseases and preparation method thereof
12/19/2012CN102824618A Group of tablets for promoting qi circulation and relieving pain
12/19/2012CN102824615A Medicinal composition used for cold evil caused faint symptoms of domestic animals
12/19/2012CN102824612A Traditional Chinese medicine for treating dilated cardiomyopathy
12/19/2012CN102824608A Externally used Chinese herba preparation for treating peripheral vascular disease
12/19/2012CN102824604A Method for preparing Chinese medicinal lotion for treating meridian stasis type closed fracture
12/19/2012CN102824594A Traditional Chinese medicine for treating vital myocarditis
12/19/2012CN102824551A Traditional Chinese medicine for treating Raynaud disease and processing technology for traditional Chinese medicine
12/19/2012CN102824501A Preparation method of Lemai granules
12/19/2012CN102824498A Application of Yinao Fujian capsule in preparing medicines for treating vasculitis
12/19/2012CN102824491A Traditional Chinese medicine tampon rod for treating hemorrhoid postoperative bleeding
12/19/2012CN102824489A Medicine for treating hypertension and preparation method for medicine
12/19/2012CN102824473A Lycium ruthenicum murr total flavonoid extract and preparation method thereof
12/19/2012CN102824468A Traditional Chinese medicine used for treating hypertensive diseases, and preparation method thereof
12/19/2012CN102824463A Traditional Chinese medicine extract for suppressing generation of in-vitro glycosylation product and extraction method
12/19/2012CN102824461A Medicine for treating hypertension and preparation method thereof
12/19/2012CN102824431A Method for extracting hawthorn flavone by using pressurized liquid extraction (APLE) technique
12/19/2012CN102824425A Method for preparing mental stress relieving tablets
12/19/2012CN102824417A New method for treating helicobacter pylori related diseases
12/19/2012CN102824399A Oil-in-water type sotalol and eucommia seed oil nanoemulsion antihypertensive drug
12/19/2012CN102824395A Five-high controlling tablets
12/19/2012CN102824394A Method for synchronously extracting and separating icariin and icarisid II from herba epimedii
12/19/2012CN102824390A Xuesaitong tablets and preparation method thereof
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1595